The DOI matches its Crossref record.
Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“While H89 and BLU0588 both occupy the same hydrophobic shell that surrounds the adenine and ribose-rings of ATP, H89, unlike BLU0588, is firmly anchored to the catalytic loop through its interactions with Asn171 (H89; PDB ID: 1YDT) (Fig. 6) (54).”
From A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit (2026) · cites this paper as [54]
In the citing paper
“While H89 and BLU0588 both occupy the same hydrophobic shell that surrounds the adenine and ribose-rings of ATP, H89, unlike BLU0588, is firmly anchored to the catalytic loop through its interactions with Asn171 (H89; PDB ID: 1YDT) (Fig. 6) (54).”
From A PKA-selective inhibitor captures an open but more ordered conformation of the PKA catalytic subunit (2026) · cites this paper as [54]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 51
- Omura, 1977, New alkaloid AM-2282 of Streptomyces origin – taxonomy, fermentation, isolation and preliminary characterization, J. Antibiot, 30, 275, 10.7164/antibiotics.30.275 · DOI · Paper page
- Tamaoki, 1991, Use and specificity of staurosporine, UCN-01, and calphostin C as protein kinase inhibitors, Methods Enzymol, 201, 340, 10.1016/0076-6879(91)01030-6 · DOI · Paper page
- Gadbois, 1992, Staurosporine is a potent inhibitor of p34cdc2 and p34cdc2-like kinases, Biochem. Biophys. Res. Commun, 184, 80, 10.1016/0006-291X(92)91160-R · DOI
- Tamaoki, 1986, Staurosporine, a potent inhibitor of phospholipid/Ca2+ dependent protein kinase, Biochem. Biophys. Res. Commun, 135, 397, 10.1016/0006-291X(86)90008-2 · DOI · Paper page
- Herbert, 1990, Characterization of specific binding sites for [3H]-staurosporine on various protein kinases, Biochem. Biophys. Res. Commun, 171, 189, 10.1016/0006-291X(90)91375-3 · doi:10.1016/0006-291x(90)91375-3
- Nakano, 1987, Staurosporine inhibits tyrosine-specific protein kinase activity of Rous sarcoma virus transforming protein p60, J. Antibiot. Tokyo, 40, 706, 10.7164/antibiotics.40.706 · DOI · Paper page
- Secrist, 1990, Preferential inhibition of the platelet-derived growth factor receptor tyrosine kinase by staurosporine, J. Biol. Chem, 265, 20394, 10.1016/S0021-9258(17)30517-3 · doi:10.1016/s0021-9258(17)30517-3
- Fujita-Yamaguchi, 1988, Characterization of receptor tyrosine-specific protein kinases by the use of inhibitors. Staurosporine is a 100-times more potent inhibitor of insulin receptor than IGF-I receptor, Biochem. Biophys. Res. Commun, 157, 955, 10.1016/S0006-291X(88)80967-7 · doi:10.1016/s0006-291x(88)80967-7
- Raffioni, 1995, Staurosporine causes epidermal growth factor to induce differentiation in PC12 cells via receptor up-regulation, J. Biol. Chem, 270, 7568, 10.1074/jbc.270.13.7568 · DOI
- Stanwell, 1996, Staurosporine induces a complete program of terminal differentiation in neoplastic mouse keratinocytes via activation of protein kinase C, Carcinogenesis, 17, 1259, 10.1093/carcin/17.6.1259 · doi:10.1093/carcin/17.6.1259
- Wiesner, 1996, Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway, J. Neurochem, 66, 1418, 10.1046/j.1471-4159.1996.66041418.x · DOI · Paper page
- Raff, 1993, Programmed cell death and the control of cell survival: lessons from the nervous system, Science, 262, 695, 10.1126/science.8235590 · DOI · Paper page
- Jacobson, 1994, Programmed cell death and Bcl-2 protection in the absence of a nucleus, EMBO J, 13, 1899, 10.1002/j.1460-2075.1994.tb06459.x · DOI · Paper page
- Akinaga, 1991, Antitumor activity of UCN-01, a selective inhibitor of protein kinase C, in murine and human tumor models, Cancer Res, 51, 4888
- Meyer, 1989, A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activity, Int. J. Cancer, 43, 851, 10.1002/ijc.2910430519 · DOI · Paper page
- Yanagihara, 1991, Staurosporine: an effective inhibitor for Ca2+/calmodulin-dependent protein kinase II, J. Neurochem, 56, 294, 10.1111/j.1471-4159.1991.tb02595.x · DOI
- Meggio, 1995, Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2, Eur. J. Biochem, 234, 317, 10.1111/j.1432-1033.1995.317_c.x · DOI · Paper page
- Davis, 1992, Inhibitors of protein kinase C. 2. Substituted bisindolylmaleimides with improved potency and selectivity, J. Med. Chem, 35, 994, 10.1021/jm00084a004 · DOI · Paper page
- Engh, 1996, Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89 – structural implications for selectivity, J. Biol. Chem, 271, 26157, 10.1074/jbc.271.42.26157 · DOI · Paper page
- Schulze-Gahmen, 1996, High-resolution crystal structures of human cyclin-dependent kinase 2 with and without ATP: bound waters and natural ligand as guides for inhibitor design, J. Med. Chem, 39, 4540, 10.1021/jm960402a · DOI · Paper page
- De-Azevedo, 1996, Structural basis for specificity and potency of a flavonoid inhibitor of human CDK2, a cell cycle kinase, Proc. Natl. Acad. Sci. USA, 93, 2735, 10.1073/pnas.93.7.2735 · DOI · Paper page
- Xu, 1996, Structural basis for selectivity of the isoquinoline sulfonamide family of protein kinase inhibitors, Proc. Natl. Acad. Sci. USA, 93, 6308, 10.1073/pnas.93.13.6308 · DOI
- Mohammadi, 1997, Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors, Science, 276, 955, 10.1126/science.276.5314.955 · DOI · Paper page
- Tong, 1997, A highly specific inhibitor of human p38 MAP kinase binds in the ATP pocket, Nat. Struct. Biol, 4, 311, 10.1038/nsb0497-311 · DOI · Paper page
- Furet, 1995, Modelling study of protein kinase inhibitors: binding mode of staurosporine and origin of the selectivity of CGP 52411, J. Comput. Aided Mol. Des, 9, 465, 10.1007/BF00124317 · DOI
- Takagi, 1996, Inhibition mechanisms of staurosporine and h7 to cAMP-dependent protein kinase through docking study, Chem. Pharmaceut. Bull, 44, 618, 10.1248/cpb.44.618 · doi:10.1248/cpb.44.618
- Wiemann, 1992, Cloning of the C alpha catalytic subunit of the bovine cAMP-dependent protein kinase, Biochim. Biophys. Acta, 1171, 93, 10.1016/0167-4781(92)90144-O · DOI
- Knighton, 1991, Crystal structure of the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase, Science, 253, 407, 10.1126/science.1862342 · DOI · Paper page
- Narayana, 1997, Crystal structure of a polyhistidine-tagged recombinant catalytic subunit of cAMP-dependent protein kinase complexed with the peptide inhibitor PKI(5–24) and adenosine, Biochemistry, 36, 4438, 10.1021/bi961947+ · DOI
- Zheng, 1993, Crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with MgATP and peptide inhibitor, Biochemistry, 32, 2154, 10.1021/bi00060a005 · DOI · Paper page
- Bossemeyer, 1993, Phosphotransferase and substrate binding mechanism of the cAMP-dependent protein kinase catalytic subunit from porcine heart as deduced from the 2.0 Å structure of the complex with Mn2+ adenylyl imidodiphosphate and inhibitor peptide PKI(5–24), EMBO J, 12, 49, 10.1002/j.1460-2075.1993.tb05725.x · DOI · Paper page
- Karlsson, 1993, The crystal structure of the mammalian catalytic subunit of cAMP-dependent protein kinase and an inhibitor peptide displays an open conformation, Acta Cryst. D, 49, 381, 10.1107/S0907444993002306 · DOI
- Narayana, 1997, A binary complex of the catalytic subunit of cAMP-dependent protein kinase and adenosine further defines conformational flexibility, Structure, 5, 921, 10.1016/S0969-2126(97)00246-3 · DOI · Paper page
- Zheng, 1993, Crystal structures of the myristylated catalytic subunit of cAMP-dependent protein kinase reveal open and closed conformations, Protein Sci, 2, 1559, 10.1002/pro.5560021003 · DOI · Paper page
- Hanks, 1991, Protein kinase catalytic domain sequence database: identification of conserved features of primary structure and classification of family members, Methods Enzymol, 200, 38, 10.1016/0076-6879(91)00126-H · DOI · Paper page
- Knighton, 1993, 2.0 Å refined crystal structure of the catalytic subunit of cAMP-dependent protein kinase complexed with a peptide inhibitor and detergent, Acta Cryst. D, 49, 357, 10.1107/S0907444993000502 · DOI
- Lew, 1997, Synergistic binding of nucleotides and inhibitors to cAMP-dependent protein kinase examined by acrylodan fluorescence spectroscopy, J. Biol. Chem, 272, 1507, 10.1074/jbc.272.3.1507 · doi:10.1074/jbc.272.3.1507
- Hartl, 1983, Adenosine cyclic 3′,5′-monophosphate dependent protein kinase: interaction of the catalytic subunit and holoenzyme with linbenzoadenine nucleotides, Biochemistry, 22, 2347, 10.1021/bi00279a007 · doi:10.1021/bi00279a007
- Schulze-Gahmen, 1995, Multiple modes of ligand recognition: crystal structures of cyclin-dependent protein kinase 2 in complex with ATP and two inhibitors, olomoucine and isopentenyladenine, Proteins, 22, 378, 10.1002/prot.340220408 · DOI · Paper page
- Bossemeyer, 1994, The glycine-rich sequence of protein kinases: a multifunctional element, Trends Biochem. Sci, 19, 201, 10.1016/0968-0004(94)90022-1 · DOI · Paper page
- Longenecker, 1996, Three-dimensional structure of mammalian casein kinase I: molecular basis for phosphate recognition, J. Mol. Biol, 257, 618, 10.1006/jmbi.1996.0189 · DOI
- Herberg, 1993, Expression of the catalytic subunit of cAMP-dependent protein kinase in Escherichia coli – multiple isozymes reflect different phosphorylation states, Protein Eng, 6, 771, 10.1093/protein/6.7.771 · doi:10.1093/protein/6.7.771
- Girod, 1996, In vivo activation of recombinant cAPK catalytic subunit active site mutants by coexpression of the wild type enzyme, evidence for intermolecular cotranslational phosphorylation, FEBS Lett, 391, 121, 10.1016/0014-5793(96)00717-X · DOI
- 1994, The CCP4 suite: programs for protein crystallography, Acta Cryst. D, 50, 760, 10.1107/S0907444994003112 · DOI · Paper page
- Navaza, 1994, AMoRe: an automated package for molecular replacement, Acta Cryst. A, 50, 157, 10.1107/S0108767393007597 · DOI · Paper page
- Brünger, 1992, Free R-value – a novel statistical quantity for assessing the accuracy of crystal structures, Nature, 355, 472, 10.1038/355472a0 · DOI · Paper page
- Engh, 1991, Accurate bond and angle parameters for X-ray protein structure refinement, Acta Cryst. A, 47, 392, 10.1107/S0108767391001071 · DOI · Paper page
- Jones, 1991, Improved methods for building protein models in electron-density maps and location of errors in these models, Acta Cryst. A, 47, 110, 10.1107/S0108767390010224 · DOI · Paper page
- Furusaki, 1978, X-ray crystal-structure of staurosporine – new alkaloid from a Steptomyces strain, J. Chem. Soc. Chem. Commun, 18, 800, 10.1039/C39780000800 · doi:10.1039/c39780000800
- Funato, 1994, Absolute configuration of staurosporine by X-ray analysis, Tetrahedron Lett, 35, 1251, 10.1016/0040-4039(94)88036-0 · doi:10.1016/0040-4039(94)88036-0
- Kleywegt, 1994, A super position, ESF/CCP4 Newsletter, 31, 9
Cited by
Walker, E. H., Pacold, M. E., Perisic, O., Stephens, L., Hawkins, P. T., Wymann, M. P., & Williams, R. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00089-4 · Cited by 1,197
Indolocarbazole natural products: occurrence, biosynthesis, and biological activity
Sánchez, C., Méndez, C., & Salas, J. A. (2006) · Nat. Prod. Rep. · doi:10.1039/b601930g · Cited by 407
Dynamics of cAMP-Dependent Protein Kinase
Johnson, D. A., Akamine, P., Radzio-Andzelm, E., Madhusudan, & Taylor, S. S. (2001) · Chemical Reviews · doi:10.1021/cr000226k · Cited by 393
The chemistry of isoindole natural products
Speck, K., & Magauer, T. (2013) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.9.243 · Cited by 383
Bertrand, J. A., Thieffine, S., Vulpetti, A., Cristiani, C., Valsasina, B., Knapp, S., Kalisz, H. M., & Flocco, M. (2003) · Journal of Molecular Biology · doi:10.1016/j.jmb.2003.08.031 · Cited by 319
Metadata
- Authors
- Prade, L., Engh, R. A., Girod, A., Kinzel, V., Huber, R., & Bossemeyer, D.
- Venue
- Structure
- Publisher
- Elsevier BV
- Published
- 1997-12
- Volume
- 5
- Issue
- 12
- Pages
- 1627-1637
- ISSN
- 0969-2126
- Cited by
- 136
- References
- 0
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 5707 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential. https://app.cochat.ai/papers/10.1016/s0969-2126(97)00310-9
- The paper
- Prade, L., Engh, R. A., Girod, A., Kinzel, V., Huber, R., & Bossemeyer, D. (1997). Staurosporine-induced conformational changes of cAMP-dependent protein kinase catalytic subunit explain inhibitory potential. Structure. https://doi.org/10.1016/s0969-2126(97)00310-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.